On Nov 21, major Wall Street analysts update their ratings for $Medtronic (MDT.US)$, with price targets ranging from $87 to $105.
Citi analyst Joanne Wuensch maintains with a hold rating, and maintains the target price at $92.
Barclays analyst Matt Miksic maintains with a buy rating, and maintains the target price at $105.
Wells Fargo analyst Larry Biegelsen maintains with a buy rating, and maintains the target price at $98.
TD Cowen analyst Josh Jennings maintains with a buy rating, and maintains the target price at $95.
Mizuho Securities analyst Anthony Petrone maintains with a buy rating.
Furthermore, according to the comprehensive report, the opinions of $Medtronic (MDT.US)$'s main analysts recently are as follows:
While maintaining a positive outlook on the FY25 high single digit EPS growth exit rate as an indicator for future potential, it is anticipated that into FY26, the company will face challenges from ongoing foreign exchange pressures, dilutive impacts from new product introductions and capital rollouts, along with a minor tax disadvantage, potentially restricting a sustained return to high single digit EPS growth.
Following a recent quarterly report, Medtronic's revenue surpassed expectations, driven by performance in its cardiovascular, neuro, and diabetes sectors. Additionally, the company has raised its fiscal year 2025 guidance to between 4.75%-5.0%. Looking further ahead to fiscal year 2026, analysts predict that earnings growth may exceed revenue growth.
Here are the latest investment ratings and price targets for $Medtronic (MDT.US)$ from 7 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
